Telsey Advisory Group has raised its Q4 2026 earnings estimates for Five Below, signaling increased confidence in the specialty retailer’s future performance. This move comes as Five Below reported earnings and revenue that surpassed analysts’ expectations, highlighting the company’s robust growth.

HashKey Group forecasts a significant surge in the cryptocurrency market by 2025, predicting Bitcoin will soar to $300,000. The group’s report highlights regulatory shifts, technological advancements, and traditional capital inflows as key drivers of this growth.

In a surprising twist, bond yields are surging even as the Federal Reserve cuts interest rates, leaving investors uneasy. The 10-year Treasury yield has climbed above 4.80%, its highest level since 2023, unsettling stock markets and knocking indexes off their records.

Allstate’s stock is experiencing a noticeable decline, and it’s not just the Los Angeles fires impacting the insurer. Multiple challenges are weighing on the company’s financial performance, raising concerns among investors.

As Meta’s stock shows signs of a bearish shift, investors are considering strategic short positions to capitalize on potential price declines. Technical analysis suggests resistance near key price levels, opening opportunities for trades with a favorable reward-to-risk ratio.

A seasoned Wall Street trader has unveiled his top stock pick for 2025—a company set to rival Nvidia in the competitive fields of artificial intelligence and semiconductors. His insights could have significant implications for investors tracking the tech sector.

Shares of Moderna tumbled sharply on Monday after the vaccine maker projected a larger-than-anticipated drop in sales for 2025. The unexpected forecast surprised analysts and investors, signaling potential challenges ahead for the biotech firm.

Visa Inc. is under legal scrutiny as investors file a class action lawsuit alleging the company concealed non-compliance with federal antitrust laws, leading to significant financial losses. Affected shareholders have until January 21, 2025, to seek appointment as lead plaintiff in the case led by Levi & Korsinsky, LLP.

After Twilio’s remarkable surge, investors are turning to Bandwidth, a cloud communications company showing impressive growth and the potential for significant gains.

Applied Therapeutics is under fire as investors file a class action lawsuit following the FDA’s refusal to approve its lead drug, causing stock prices to plummet over 80%. Investors have until February 18, 2025, to join the lawsuit alleging securities fraud.

Investors have filed a class action lawsuit against Rentokil Initial plc, alleging securities fraud related to the company’s integration of Terminix. The lawsuit claims that Rentokil concealed significant challenges, negatively impacting investors.

Kyverna Therapeutics faces a class action lawsuit alleging the company made false statements and concealed critical information during its February 2024 IPO. Investors who purchased stock may be eligible to join the lawsuit led by Levi & Korsinsky, LLP.

Warner Bros. Discovery is confronting a class action lawsuit alleging that the company misled investors through false statements about its financial prospects during critical NBA negotiations.

Investors in MGP Ingredients, Inc. are being notified of a class action lawsuit alleging the company misled shareholders about demand and inventory levels in its brown goods segment. The lawsuit, led by Levi & Korsinsky, LLP, seeks to recover losses for investors affected between May 4, 2023, and October 30, 2024. The deadline to seek lead plaintiff status is February 14, 2025.

Investors have filed a class action lawsuit against Wolfspeed, Inc. after the company’s stock dropped by over 39% in a single day. The lawsuit alleges that Wolfspeed misled shareholders with revenue projections tied to its Mohawk Valley fabrication facility.

Investors have filed a class-action lawsuit against ASP Isotopes Inc., alleging the company misled shareholders by overstating its technology’s effectiveness and business prospects. Affected investors have until February 3, 2025, to join the lawsuit with no cost or obligation to participate.

Zeta Global Holdings Corp. is facing a class action lawsuit filed by Levi & Korsinsky, LLP, accusing the company of securities fraud that allegedly misled investors and artificially inflated financial results. Affected investors have until January 21, 2025, to join the lawsuit.

Investors in Humacyte, Inc. have filed a class action lawsuit alleging securities fraud against the company. The suit claims that Humacyte concealed critical manufacturing deficiencies, leading to investor losses. Affected shareholders have until January 17, 2025, to seek lead plaintiff status.

Investors in Joint Stock Company Kaspi.kz have until February 18, 2025, to join a class action lawsuit alleging securities fraud and undisclosed risks. The lawsuit, led by Levi & Korsinsky, LLP, accuses the company of misleading shareholders about business dealings and executive connections.

Investors in Celsius Holdings, Inc. have been notified of a class action lawsuit alleging securities fraud committed between February 2024 and September 2024. Levi & Korsinsky, LLP urges affected shareholders to act before the January 21, 2025, deadline to seek potential recovery of losses.